Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 August;56(4)

ULTIMO FASCICOLOTHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Rivista di Medicina Nucleare e Imaging Molecolare


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


Periodicità: Trimestrale

ISSN 1824-4785

Online ISSN 1827-1936


eTOC

 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 August;56(4)

 FOREWORD AN UPDATE ON MOLECULAR IMAGING OF PROSTATE CANCER (Part I) 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 August;56(4):319-20

Molecular imaging for prostate cancer diagnosing and for guiding tailored therapies

Picchio M., de Jong I. J.


 REVIEWS AN UPDATE ON MOLECULAR IMAGING OF PROSTATE CANCER (Part I) 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 August;56(4):321-30

Clinical and diagnostic assessment for therapeutic decisions in prostate cancer

Passoni N. M., Di Trapani E., Suardi N., Gallina A., Abdollah F., Bianchi M., Picchio M., Giovacchini G., Messa C., Rigatti P., Montorsi F., Briganti A.


 REVIEWS AN UPDATE ON MOLECULAR IMAGING OF PROSTATE CANCER (Part I) 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 August;56(4):331-42

Conventional imaging and Multiparametric Magnetic Resonance (MRI, MRS, DWI, MRP) in the diagnosis of prostate cancer

Panebianco V., Sciarra A., Marcantonio A., Forte V., Biondi T., Laghi A., Catalano C.


 REVIEWS AN UPDATE ON MOLECULAR IMAGING OF PROSTATE CANCER (Part I) 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 August;56(4):343-53

PET/CT and choline: diagnosis and staging

Farsad M., Schwarzenböck S., Krause B. J.


 REVIEWS AN UPDATE ON MOLECULAR IMAGING OF PROSTATE CANCER (Part I) 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 August;56(4):354-66

Restaging prostate cancer patients with biochemical failure with PET/CT and radiolabeled choline

Giovacchini G., Breeuwsma A. J.


 REVIEWS AN UPDATE ON MOLECULAR IMAGING OF PROSTATE CANCER (Part I) 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 August;56(4):367-74

PET/CT in prostate cancer: non-choline radiopharmaceuticals

Castellucci P., Jadvar H.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 August;56(4):375-84

Comparison of 18F-FDG positron emission tomography/computed tomography and computed tomography in patients with already-treated breast cancer: diagnostic and prognostic implications

Evangelista L., Baretta Z., Vinante L., Bezzon E., De Carolis V., Cervino A. R., Gregianin M., Ghiotto C., Saladini G., Pomerri F., Muzzio P. C.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 August;56(4):385-99

Molybdenum-99 production from reactor irradiation of molybdenum targets: a viable strategy for enhanced availability of technetium-99m

Pillai M. R. A., Knapp F. F. (Russ) Jr.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 August;56(4):400-8

Development and testing of a new disposable sterile device for labelling white blood cells

Signore A., Glaudemans A. W. J. M., Malviya G., Lazzeri E., Prandini N., Viglietti A. L., De Vries E. F. J., Dierckx R. A. J. O.


inizio pagina